IDEX Corporation provided earnings guidance for the second quarter and full year 2022. Full year 2022 organic sales growth is projected to be 6% to 8%, with an 8% to 9% organic sales increase in the second quarter of 2022 versus the prior year period. The company expected full year 2022 reported EPS attributable to IDEX of $6.87 to $7.00 and second quarter 2022 reported EPS attributable to IDEX of $1.69 to $1.74.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
221.6 USD | -0.35% | -1.67% | +2.10% |
May. 16 | IDEX Biometrics Completes Upsized NOK55 Million Share Placement | MT |
May. 08 | Declaration of Voting Results by IDEX Corporation | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.10% | 16.83B | |
-3.74% | 14.04B | |
+21.64% | 6.53B | |
-4.46% | 5.18B | |
+3.92% | 4.61B | |
+39.10% | 2.01B | |
+108.07% | 1.76B | |
+3.01% | 1.25B | |
+22.41% | 1.05B | |
-7.74% | 854M |
- Stock Market
- Equities
- IEX Stock
- News IDEX Corporation
- IDEX Corporation Provides Earnings Guidance for the Second Quarter and Full Year 2022